SJUTS DUSTIN S (Chief Commercial Officer) sold 3.3% of their position (5K shares) of REVANCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $154.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/13/2023ACC: 0001479290-23-000079
Officer· Chief Commercial Officer
Since Dec 2019
-5K
Net shares
Net seller
$154.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$30.82
Trade value
$154.10K
% of position
3.3%
6/9/2023
152.35K→147.35K
Total
Net shares
−5K
Net value
-$154.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2023 | S · Sale | −5K | $30.82 | $154.10K | 3.3% | 152.35K | 147.35K |
| Total | −5K | -$154.10K | ||||||
Derivative Transactions0
No derivative transactions reported